Profile of Luspatercept in the Treatment of Anemia in Adults with Non-Transfusion-Dependent β-Thalassemia (NTDT): Design, Development and Potential Place in Therapy by Musallam KM, Taher AT, Kattamis A, Kuo KH, Sheth S, Cappellini MD

Get full text

Efficacy of deferasirox in patients with thalassaemia major is not affected by a history of hepatitis B OR C by Cappellini, M.D., Elalfy, M., El-Beshlawy, A., Kattamis, A., Chan, L.L., Li, C., Lin, K.H., Quarta, G., Sutcharitchan, P., Taher, A., Habr, D., Roubert, B., Porter, J.

Continued improvement in cardiac T2*with deferasirox treatment over 2 years: Results from the extension of epic cardiac substudy in beta-thalassaemia patients with myocardial sider... by Pennell, D., Porter, J., Cappellini, M., Chan, L.L., El-Beshlawy, A., Aydinok, Y., Ibrahim, H., Li, C.K., Viprakasit, V., Elalfy, M., Kattamis, A., Smith, G., Habr, D., Roubert, B., Taher, A.

Deferasirox effectively removes cardiac iron in beta-thalassaemia patients with myocardial siderosis previously chelated with deferoxamine monotherapy or deferoxamine-deferiprone t... by Pennell, D., Porter, J., Cappellini, M., Chan, L.L., El-Beshlawy, A., Aydinok, Y., Ibrahim, H., Li, C.K., Viprakasit, V., Elalfy, M., Kattamis, A., Smith, G., Habr, D., Roubert, B., Taher, A.

Continued improvement and normalization of myocardial T2*in patients with beta-thalassemia major treated with deferasirox (Exjade (R)) for up to 3 years by Pennell, D., Porter, J.B., Cappellini, M.D., Chan, L.L., El-Beshlawy, A., Aydinok, Y., Ibrahim, H., Li, Chi-Kong, Viprakasit, V., Elalfy, M.S., Kattamis, A., Smith, G., Habr, D., Domokos, G., Roubert, B., Taher, A.

Efficacy of deferasirox in reducing and preventing cardiac iron overload in beta-thalassemia by Pennell, D.J., Porter, J.B., Cappellini, M.D., El-Beshlawy, A., Chan, L.L., Aydinok, Y., Elalfy, M.S., Sutcharitchan, P., Li, C.K., Ibrahim, H., Viprakasit, V., Kattamis, A., Smith, G., Habr, D., Domokos, G., Roubert, B., Taher, A.

Recommendations regarding splenectomy in hereditary hemolytic anemias by Iolascon, A, Andolfo, I, Barcellini, W, Corcione, F, Garçon, L, De Franceschi, L, Pignata, C, Graziadei, G, Pospisilova, D, Rees, DC, de Montalembert, M, Rivella, S, Gambale, A, Russo, R, Ribeiro, L, Vives-Corrons, J, Martinez, PA, Kattamis, A, Gulbis, B, Cappellini, MD, Roberts, I, Tamary, H

Tailoring iron chelation by iron intake and serum ferritin: The prospective EPIC study of deferasirox in 1744 patients with transfusion-dependent anemias by Cappellini, M.D., Porter, J., El-Beshlawy, A., Li, C.K., Seymour, J.F., Elalfy, M., Gattermann, N., Giraudier, S., Lee, J.W., Chan, L.L., Lin, K.H., Rose, C., Taher, A., Thein, S.L., Viprakasit, V., Habr, D., Domokos, G., Roubert, B., Kattamis, A., Investigators, EPIC Study

Identification of a new VHL exon and complex splicing alterations in familial erythrocytosis or von Hippel-Lindau disease by Lenglet, M, Robriquet, F, Schwarz, K, Camps, C, Couturier, A, Hoogewijs, D, Buffet, A, Knight, SJ, Gad, S, Couvé, S, Chesnel, F, Pacault, M, Lindenbaum, P, Job, S, Dumont, S, Besnard, T, Cornec, M, Dreau, H, Pentony, M, Kvikstad, E, Deveaux, S, Burnichon, N, Ferlicot, S, Vilaine, M, Mazzella, J-M, Airaud, F, Garrec, C, Heidet, L, Irtan, S, Mantadakis, E, Bouchireb, K, Debatin, K-M, Redon, R, Bezieau, S, Paillerets, B, Teh, BT, Girodon, F, Randi, M-L, Putti, MC, Bours, V, Van Wijk, R, Göthert, JR, Kattamis, A, Janin, N, Bento, C, Taylor, JC, Arlot-Bonnemains, Y, Richard, S, Gimenez-Roqueplo, A-P, Cario, H, Gardie, B